CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 135 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2020. The put-call ratio across all filers is 0.02 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $9,464,000 | -16.9% | 280,008 | -32.0% | 0.06% | -31.6% |
| Q1 2021 | $11,384,000 | -4.0% | 411,515 | +0.0% | 0.10% | +1.1% |
| Q4 2020 | $11,853,000 | +50.3% | 411,512 | +5.7% | 0.09% | +27.0% |
| Q3 2020 | $7,887,000 | -33.5% | 389,320 | -1.4% | 0.07% | -40.8% |
| Q2 2020 | $11,860,000 | +108.1% | 394,652 | +218.8% | 0.12% | +98.4% |
| Q1 2020 | $5,700,000 | -2.2% | 123,784 | +0.0% | 0.06% | +1.6% |
| Q4 2019 | $5,831,000 | – | 123,774 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |